These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26794211)

  • 21. Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?
    Bellone F; Morace C; Impalà G; Viola A; Lo Gullo A; Cinquegrani M; Fries W; Sardella A; Scolaro M; Basile G; Squadrito G; Mandraffino G
    J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC; Plamondon S; Gupta A; Burling D; Kamm MA
    Aliment Pharmacol Ther; 2009 Oct; 30(7):757-66. PubMed ID: 19575762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six Cases of Lung Injury Following Anti-tumour Necrosis Factor Therapy for Inflammatory Bowel Disease.
    Lee HS; Jo KW; Shim TS; Song JW; Lee HJ; Hwang SW; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH; Yang SK
    J Crohns Colitis; 2015 Nov; 9(11):1053-7. PubMed ID: 26221002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease.
    Hauser G; Tkalcić M; Stimac D; Milić S; Sincić BM
    Coll Antropol; 2011 Sep; 35 Suppl 2():203-7. PubMed ID: 22220436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.
    Bernklev T; Jahnsen J; Henriksen M; Lygren I; Aadland E; Sauar J; Schulz T; Stray N; Vatn M; Moum B
    Inflamm Bowel Dis; 2006 May; 12(5):402-12. PubMed ID: 16670530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
    Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
    Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life among patients with primary sclerosing cholangitis.
    Haapamäki J; Tenca A; Sintonen H; Barner-Rasmussen N; Färkkilä MA
    Liver Int; 2015 Sep; 35(9):2194-201. PubMed ID: 25546575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.
    Bastida G; Nos P; Aguas M; Beltrán B; Iborra M; Ortiz V; Garrigues V; Estevan R; Ponce J
    BMC Gastroenterol; 2010 Mar; 10():26. PubMed ID: 20196836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?
    Horváth G; Farkas K; Hollósi R; Nagy F; Szepes Z; Papp M; Palatka K; Miheller P; Lakatos L; Szamosi T; Nyári T; Wittmann T; Molnár T
    Scand J Gastroenterol; 2012 Nov; 47(11):1298-303. PubMed ID: 22935014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.
    Vogelaar L; Spijker AV; van der Woude CJ
    Clin Exp Gastroenterol; 2009; 2():101-9. PubMed ID: 21694833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease.
    Abdovic S; Pavic AM; Milosevic M; Persic M; Senecic-Cala I; Kolacek S
    Inflamm Bowel Dis; 2015 Apr; 21(4):818-23. PubMed ID: 25742398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.
    Alexandre B; Vandermeeren Y; Dewit O; Moreels T; de Boer N; Dhar A; Ziady C; Shitrit AB; Steinwurz F; Jojic N; Costantino G; Bihin B; Rahier JF; Katsanos KH;
    J Crohns Colitis; 2016 May; 10(5):541-8. PubMed ID: 26759360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.
    Principi M; Losurdo G; La Fortezza RF; Lopolito P; Lovero R; Grillo S; Bringiotti R; Ierardi E; Di Leo A
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):165-70. PubMed ID: 26114175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn's Disease.
    Fiorino G; Bonifacio C; Allocca M; Repici A; Balzarini L; Malesci A; Peyrin-Biroulet L; Danese S
    J Crohns Colitis; 2015 Aug; 9(8):633-9. PubMed ID: 25958059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoration of quality of life of patients with inflammatory bowel disease after one year with antiTNFα treatment.
    Casellas F; Robles V; Borruel N; Torrejón A; Castells I; Navarro E; Guarner F
    J Crohns Colitis; 2012 Oct; 6(9):881-6. PubMed ID: 22398074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics.
    Haapamäki J; Tanskanen A; Roine RP; Blom M; Turunen U; Mäntylä J; Färkkilä MA; Arkkila PE
    Scand J Gastroenterol; 2013 Jan; 48(1):42-50. PubMed ID: 23163864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    Corica D; Romano C
    J Clin Gastroenterol; 2017 Feb; 51(2):100-110. PubMed ID: 27636407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study.
    Revicki DA; Menter A; Feldman S; Kimel M; Harnam N; Willian MK
    Health Qual Life Outcomes; 2008 Oct; 6():75. PubMed ID: 18831744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.
    Gagniere C; Beaugerie L; Pariente B; Seksik P; Amiot A; Abitbol V; Allez M; Cosnes J; Sokol H
    J Crohns Colitis; 2015 Apr; 9(4):349-55. PubMed ID: 25547977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.